Yaniv Sneor

@ysneor had the opportunity to chat with @BKRBusinessMin all things #MABA #BeckerBusinessminute #lifesciences #angelinvesting twitter.com/BKRBusinessMin…

Join our Co-Founder and CEO @ysneor on April 18th, 2-3 pm for a special webinar on angel investing hosted by the @nasdaqcenter in partnership with @ACAAngelCapital #angelinvestors #lifesciences #MABA lnkd.in/ePvcST_F

MABA is excited to announce our investment in veterinary biotech company Hilltop Bio! #MABAbacked #angelinvestors #lifesciences einpresswire.com/article/624954…

Looking for a part time administrator to assist with the operations of a membership organization. Please send a cover letter and resume to jobs@bioangels.net linkedin.com/posts/mid-atla…

MABA's active and accredited life science investors (bioangels.net/individual-mem…), both individuals and corporates, who are joined by accredited investors interested in diversifying their portfolio by investing alongside MABA via the MABA Sidecar Fund II (bioangels.net/sidecar-fund-i…)

Happy to announce the acquisition of our portfolio company - @IncCerus - by @Stryker_NV! MABA and the MABA syndicate accounted for the majority of Cerus’ funding over several rounds, including an investment from our internal investment Pool and our first Sidecar Fund.

Wow. A wearable ultrasound patch for continuous, on the go, high-quality imaging of most parts the human body. A remarkable new innovation with diverse clinical applications @ScienceMagazine science.org/doi/10.1126/sc… @ProfZhaoMIT @ChongheWang @MIT @MITMechE

Congratulations to our MABA portfolio company, @AstrocytePharma, for achieving this major milestone! First-In-Human Phase 1 Study of AST-004, a promising stroke and traumatic brain injury therapeutic! #angelinvestors #MABAbacked #MABA #lifesciences astrocytepharma.com/2022/06/astroc…

That's a good data. Yes you are!

Happening soon at 11 - will be moderating an Early Stage Life Science Investing panel at #RESI2022 resiconference.com/panels/

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? investors.com/news/technolog… via @IBDinvestors

@stuartbuck1 Thank you @stuartbuck1, for tackling this important issue. I think that the causes are generally known and identifiable and that real solutions exist within grasp.

A new piece I published today: statnews.com/2022/02/01/kar…

@BioAngelsGroup sponsor @RBWConsulting is hosting a webinar "An Emotional Odyssey – The Mental Health Impact of a Rare Disease Diagnosis"on Feb 22nd. Check it out at: eventbrite.co.uk/e/an-emotional…

Busy week! Looking forward to #JPM2022, #BiotechShowcase, #RESI, @IAmBiotech partnering events and participating on a medical device investor panel at Digital RESI (resiconference.com/panels/).

Astrocyte is excited to announce this new $500K grant from @MTEC_SC and @_BrightFocus to keep advancing AST-004 for #TBI, #concussion, and #Alzheimers! astrocytepharma.com/2021/09/astroc…

Landmark gene therapy trial points to a wider window to alter course of rare disease statnews.com/2021/07/12/gen… via @statnews

A proposed ‘quantum compass’ for songbirds just got more plausible sciencenews.org/article/quantu…

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM nejm.org/doi/full/10.10…

New View Surgical received 510(k) clearance from the #FDA for its #VisionPort System. Congratulations to Bryce Klontz and the @NewViewSurg team! #lifesciences #AngelInvestors #MABABacked businesswire.com/news/home/2021…

🗣️In the first roundtable of the session tomorrow 22 June, dedicated to Private investment in the healthcare sector, we will count on investors leaders from USA and Spain to lead the debate #Health #TimeForTransformation REGISTER NOW 👉eithealth.eventscase.com/EN/health_time…